No Data
No Data
Earnings Call Summary | ScPharmaceuticals(SCPH.US) Q4 2024 Earnings Conference
ScPharmaceuticals Outlines FUROSCIX Expansion Strategy With CKD Launch in April 2025
scPharmaceuticals | 10-K: Annual report
ScPharmaceuticals, Inc. (SCPH) Reports Q4 Loss, Tops Revenue Estimates
ScPharmaceuticals GAAP EPS of -$0.35 Beats by $0.03, Revenue of $12.2M Beats by $0.02M
Express News | ScPharmaceuticals Q4 Revenue USD 12.15 Million Vs. IBES Estimate USD 12.1 Million
Trytosaveabit OP : Second bullet points is crazy increase! Hehehe